You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 54738-0541


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 54738-0541

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
ASPIRIN 325MG TAB Richmond Pharmaceuticals Inc. 54738-0541-02 500 5.95 0.01190 2024-02-15 - 2029-02-14 FSS
ASPIRIN 325MG TAB Richmond Pharmaceuticals Inc. 54738-0541-01 100 0.94 0.00940 2024-02-15 - 2029-02-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Market Analysis and Price Projections for the Drug NDC: 54738-0541

Introduction to the National Drug Code (NDC)

The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. The NDC 54738-0541 corresponds to Aspirin 325mg tablets manufactured by Richmond Pharmaceuticals Inc.[5].

Market Context: Overall Pharmaceutical Trends

The pharmaceutical market, including both prescription and over-the-counter (OTC) drugs, is experiencing significant changes and growth. Here are some key trends:

  • Specialty Pharmaceuticals: The market is seeing a rise in specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions. This segment is expected to drive a 3.8% increase in drug price inflation, with a projected price increase for specialty medications at 4.18%[2].
  • OTC Drugs Market: The U.S. OTC drugs market is estimated to grow from USD 42.80 billion in 2024 to USD 53 billion by 2029, driven by the high cost of prescription drugs and increased OTC drug approvals[3].

Aspirin Market Analysis

Aspirin, a widely used OTC medication, is a staple in many households and medical facilities.

Current State of Aspirin Market

  • Price Trends: The prices of Aspirin 325mg tablets, identified by NDC 54738-0541, vary based on the package size. For example, a package of 100 tablets is priced at $0.94, while a package of 500 tablets is priced at $5.95[5].
  • Vendor and Distribution: Richmond Pharmaceuticals Inc. is one of the vendors supplying Aspirin under this NDC. The distribution channels include various pharmacies and retail outlets.

Factors Influencing Prices

  • Raw Material Costs: Fluctuations in the cost of raw materials can impact the final price of Aspirin.
  • Regulatory Environment: Changes in regulatory policies, such as those related to manufacturing and distribution, can affect production costs and subsequently the market price.
  • Market Demand: Increased demand, particularly during health crises or public health campaigns, can drive up prices.

Price Projections

Short-Term Projections

  • Given the stable demand for Aspirin and the absence of significant changes in raw material costs or regulatory environments, the prices for Aspirin 325mg tablets under NDC 54738-0541 are likely to remain relatively stable in the short term.
  • Minor fluctuations may occur based on seasonal demand or temporary supply chain disruptions.

Long-Term Projections

  • Over the next few years, the prices might see a slight increase due to general inflation and potential increases in raw material costs.
  • The overall pharmaceutical market trend of a 3.8% price increase driven by specialty pharmaceuticals may not directly impact OTC drugs like Aspirin, but it could contribute to a broader inflationary environment that affects all drug prices[2].

Market Competition and Consumer Behavior

  • Market Competition: The Aspirin market is highly competitive with multiple manufacturers and brands available. This competition helps keep prices relatively stable.
  • Consumer Behavior: Consumers often opt for generic or store-brand versions of Aspirin, which can be cheaper. This behavior can influence the pricing strategy of branded Aspirin products.

Regulatory Considerations

  • FDA Regulations: The FDA's National Drug Code Directory ensures that all drug products, including Aspirin, are properly listed and regulated. Any changes in FDA regulations or compliance requirements can impact the production and pricing of Aspirin[1][4].

Conclusion

The market for Aspirin, particularly under the NDC 54738-0541, is expected to remain stable with minor fluctuations in the short term. Long-term projections suggest a potential for slight price increases due to broader market and economic factors.

Key Takeaways

  • Stable Demand: Aspirin is a staple medication with consistent demand.
  • Regulatory Compliance: Adherence to FDA regulations is crucial for maintaining market presence.
  • Market Competition: High competition in the OTC market helps keep prices stable.
  • Long-Term Projections: Potential for slight price increases due to inflation and raw material costs.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs[4].
  2. Who manufactures Aspirin under NDC 54738-0541?

    • Richmond Pharmaceuticals Inc. manufactures Aspirin under this NDC[5].
  3. What factors influence the price of Aspirin?

    • Factors include raw material costs, regulatory environment, and market demand.
  4. How does the overall pharmaceutical market trend affect Aspirin prices?

    • While specialty pharmaceutical trends may not directly impact OTC drugs like Aspirin, broader inflationary trends could influence prices.
  5. What is the projected growth rate for the U.S. OTC drugs market?

    • The U.S. OTC drugs market is expected to grow at a CAGR of 4.40% from 2024 to 2029[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient, Inc.
  3. U.S. OTC Drugs Market Forecast Report 2024-2029 - GlobeNewswire
  4. National Drug Code Database Background Information - FDA
  5. Drug prices and trends for ASPIRIN - DrugPatentWatch

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.